Skip to main content
Menu
Revvity logo
Contact us

Loading...

US
Search all

Loading...

Revvity Sites Globally

Select your location.

*e-commerce not available for this region.

australia.webp Australia
austria.webp Austria
belgium.webp Belgium
brazil.webp Brazil *
canada.webp Canada
china.webp China *
denmark.webp Denmark
finland.webp Finland
france.webp France
germany.webp Germany
hong-kong.webp Hong Kong *
india.webp India *
ireland.webp Ireland
italy.webp Italy
japan.webp Japan *
luxembourg.webp Luxembourg
mexico.webp Mexico *
netherlands.webp Netherlands
norway.webp Norway
philippines.webp Philippines *
republic of korea.webp Republic of Korea *
singapore.webp Singapore *
spain.webp Spain
sweden.webp Sweden
switzerland.webp Switzerland
thailand.webp Thailand *
uk.webp United Kingdom
usa.webp United States
Login/Register here
Revvity web shop online account

Get exclusive pricing on all online purchases.

Login to your Revvity.com account for your account's pricing, easy re-ordering from favorites & order history, priority order processing, and dynamic order tracking.

Login Register
Revvity Omics portal accounts

Initiate a new order or access test status and results for clinical genomics or newborn screening services.

View login options
Breadcrumb
...
  • Home
  • Blog
  • Disease Research
  • High-content imaging siRNA screens identify trafficking factors in Alphavirus infection.
sirna 1920x640

Blog

Disease Research

Jul 23rd 2024

3 min read

High-content imaging siRNA screens identify trafficking factors in Alphavirus infection.

Help us improve your Revvity blog experience!

Feedback

The complex relationship between a virus and its host is one of the hottest topics in science right now, and has been given considerable attention in recent weeks as a result of the race to understand the virus that causes COVID-19 and its potential vulnerabilities.

It is longstanding knowledge that viruses cannot replicate without a host. However, the method by which a virus enters its host and replicates can vary immensely from one pathogen to another. In order to halt replication, scientists must have a critical understanding of each individual pathogen’s favored modality. This is easier said than done, given that viruses accomplish their mission at the molecular level. They are capable of hijacking single host proteins and receptors, then harnessing cellular machinery to manufacture progeny.

Imaging Modalities Help Visualize and Confirm Findings

An emerging method of studying viruses is by using high-content imaging solutions to visualize the activity of small interfering RNA (siRNA), also known as short interfering RNA or “silencing” RNA. RNA is the blueprint from which proteins are translated; these proteins then go on to direct activities of the cell. The role of siRNA, as the term “silencing” would suggest, is to tamp down the expression of certain proteins and ensure their roles are not fulfilled. If one of these proteins or receptors is needed by a virus, its absence can result in the virus’ inability to enter the host and replicate. The intentional silencing of certain gene products, known as siRNA-mediated knockdown, can help scientists elucidate the in-vivo factors required by a virus; today’s ultra high-quality imaging modalities can assist in visualizing and confirming findings.

Knockdown of Host Factors May Decrease Infection Rate

A prime example of this technique is demonstrated in the recent study of cellular factors involved in the replication of alphaviruses (family Togaviridae), a category that includes Chikungunya, eastern equine encephalitis virus (EEEV) and the Venezuelan equine encephalitis virus (VEEV), among others. These viruses cause debilitating outcomes in thousands of patients each year, which range from severe arthritis to cases of fatal encephalitis. As part of the study, researchers initially chose siRNA pools targeting more than 140 human trafficking genes in the VEEV. Using siRNA-mediated knockdown of 51 host factors, they determined a number of specific factors implicated in invasion, replication, and budding of VEEV, as well as alphaviruses as a group. The potential clinical takeaway of their findings was highly significant; knockdown of the 51 host factors decreased the study’s VEEV infection rate by more than 30 percent. Search Continues for Most-Targetable Vulnerabilities

However, there remained some questions regarding the specific role of certain host factors throughout different points in the viral entry process and replication cycle. Alphavirus replication is thought to initiate at the cell’s plasma membrane, but it is the endocytic internalization, or cross-membrane transit, of viral particles that is particularly pathogenic. For this reason, it was thought that those host cell factors involved in actin rearrangements (PIP5K1-alpha, Rac1, Arp2/3) were possibly the most targetable vulnerabilities in the replication of an alphavirus. Early study findings, however, also demonstrated that factors Rac1 and Arp3 seemed to be more important in later stages of infection, particularly just before “budding” of newly-synthesized viral particles. There was also identification of a certain alphavirus envelope glycoprotein, E2, which seemed to interact with actin clusters at the plasma membrane. These identified vulnerabilities, as well as those involved in initial actin-mediated endocytosis, were visualized using stimulated emission depletion (STED) microscopy and confocal microscopy imaging, which offered the paramount resolution required to confirm filamentous actin clusters in the size range of 5-11 μm. Standard electron microscopy was also used to examine the location of other cytoskeletal elements in relation to certain alphavirus-associated structures.

High-content imaging has proven to be a particularly useful modality for laboratory quantification purposes, with higher contrast capabilities allowing for improved visualization and phenotypic analysis compared to earlier imaging technology. When combined with advances in fluorescent immunostaining, high content imaging can help guide pharmaceutical and virology researchers to possible targets for future pharmacologic interventions.

Sources:
  • https://journals.plos.org/plospathogens/article?id=10.1371/journal.ppat.1005466
  • https://www.revvity.com/product/opera-phenix-plus-system-hh14001000 Opera Phenix Plus High-Content Screening System Discover
  • https://www.ncbi.nlm.nih.gov/books/NBK100913/
     

Help us improve your Revvity blog experience!

Feedback

Share this post:

  • Email
  • Facebook
  • Linkedin
  • Twitter

More Disease Research posts

What to consider when choosing a homogenizer for your lab.
Read
What to consider when selecting a centrifuge for your lab.
Read
How extracellular vesicles are reshaping biomarker discovery.
Read

Questions?
We’re here to help.

Contact us
Revvity Logo

Loading...

    ©2025 Revvity - All rights reserved

    Revvity is a trademark of Revvity, Inc. All other trademarks are the property of their respective owners.